Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Public ClinicalTrials.gov record NCT02140021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collected from patients in the laboratory may help doctors learn more about the human papillomavirus and how often anal cancer occurs in patients with cervix, vagina, or vulvar cancer.
Study identification
- NCT ID
- NCT02140021
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 409 participants
Conditions and interventions
Conditions
- Cervical Adenocarcinoma
- Cervical Adenocarcinoma In Situ
- Cervical Intraepithelial Neoplasia
- Cervical Squamous Cell Carcinoma, Not Otherwise Specified
- Cervical Squamous Intraepithelial Neoplasia
- Early Invasive Cervical Adenocarcinoma
- Early Invasive Cervical Squamous Cell Carcinoma
- High Grade Cervical Squamous Intraepithelial Neoplasia
- High Grade Vaginal Intraepithelial Neoplasia
- Low Grade Vaginal Intraepithelial Neoplasia
- Stage I Cervical Cancer AJCC v8
- Stage I Vaginal Cancer AJCC v8
- Stage I Vulvar Cancer AJCC v8
- Stage IA Cervical Cancer AJCC v8
- Stage IA Vaginal Cancer AJCC v8
- Stage IA Vulvar Cancer AJCC v8
- Stage IA1 Cervical Cancer AJCC v8
- Stage IA2 Cervical Cancer AJCC v8
- Stage IB Cervical Cancer AJCC v8
- Stage IB Vaginal Cancer AJCC v8
- Stage IB Vulvar Cancer AJCC v8
- Stage IB1 Cervical Cancer AJCC v8
- Stage IB2 Cervical Cancer AJCC v8
- Stage II Cervical Cancer AJCC v8
- Stage II Vaginal Cancer AJCC v8
- Stage II Vulvar Cancer AJCC v8
- Stage IIA Cervical Cancer AJCC v8
- Stage IIA Vaginal Cancer AJCC v8
- Stage IIA1 Cervical Cancer AJCC v8
- Stage IIA2 Cervical Cancer AJCC v8
- Stage IIB Cervical Cancer AJCC v8
- Stage IIB Vaginal Cancer AJCC v8
- Stage III Cervical Cancer AJCC v8
- Stage III Vaginal Cancer AJCC v8
- Stage III Vulvar Cancer AJCC v8
- Stage IIIA Cervical Cancer AJCC v8
- Stage IIIA Vulvar Cancer AJCC v8
- Stage IIIB Cervical Cancer AJCC v8
- Stage IIIB Vulvar Cancer AJCC v8
- Stage IIIC Vulvar Cancer AJCC v8
- Stage IV Cervical Cancer AJCC v8
- Stage IV Vaginal Cancer AJCC v8
- Stage IV Vulvar Cancer AJCC v8
- Stage IVA Cervical Cancer AJCC v8
- Stage IVA Vaginal Cancer AJCC v8
- Stage IVA Vulvar Cancer AJCC v8
- Stage IVB Cervical Cancer AJCC v8
- Stage IVB Vaginal Cancer AJCC v8
- Stage IVB Vulvar Cancer AJCC v8
- Vaginal Adenocarcinoma
- Vulvar Adenocarcinoma
- Vulvar High Grade Squamous Intraepithelial Lesion
- Vulvar Intraepithelial Neoplasia
- Vulvar Squamous Cell Carcinoma
- Vulvar Squamous Intraepithelial Lesion
Interventions
- Biospecimen Collection Procedure
- Laboratory Biomarker Analysis Other
Procedure · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 26, 2014
- Primary completion
- Jul 7, 2025
- Completion
- Jul 7, 2025
- Last update posted
- Jul 13, 2025
2014 – 2025
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lyndon Baines Johnson General Hospital | Houston | Texas | 77026-1967 | — |
| M D Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cervical Adenocarcinoma trials
Other public records listing Cervical Adenocarcinoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07454642: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors Recruiting
- NCT02257528: Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer Active, not recruiting
- NCT07020117: A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors Recruiting
- NCT02466971: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers Active, not recruiting
- NCT04622670: Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer Active, not recruiting
- NCT06543576: External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02140021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02140021 live on ClinicalTrials.gov.